Predictive value of lipoprotein(a) for assessing the prevalence and severity of lower-extremity peripheral artery disease among patients with acute coronary syndrome

被引:1
作者
Okubo, Ryo [1 ]
Nakanishi, Rine [1 ]
Oka, Yousuke [1 ]
Kojima, Yoshimasa [1 ]
Matsumoto, Shingo [1 ]
Aikawa, Hiroto [1 ]
Noike, Ryota [1 ]
Yabe, Takayuki [1 ]
Amano, Hideo [1 ]
Toda, Mikihito [1 ]
Ikeda, Takanori [1 ]
机构
[1] Toho Univ, Fac Med, Dept Cardiovasc Med, Dept Internal Med, 6-11-1 Omori Nishi Ota Ku, Tokyo 1438541, Japan
关键词
Lipoprotein(a); Lower-extremity peripheral arterial disease; Acute coronary syndrome; MYOCARDIAL-INFARCTION; RISK-FACTORS; HEART-DISEASE; OUTCOMES;
D O I
10.1007/s00380-022-02163-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipoprotein(a) [Lp(a)] is a reliable lipid marker for atherosclerosis. However, the clinical relevance of Lp(a) to lower-extremity peripheral artery disease (LE-PAD) and coronary artery disease (CAD) in the same patient has not been investigated. Patients who received primary percutaneous coronary intervention for the acute coronary syndrome (ACS) were enrolled. Patients who received hemodialysis, required multidisciplinary treatments, or had incomplete medical history were excluded. A total of 175 patients were divided into two groups according to whether they had LE-PAD (n = 21) or did not (n = 154), and three multivariable logistic regression models were used to assess if Lp(a) level is associated with LE-PAD prevalence. In addition, serum Lp(a) levels were compared among three groups according to the severity of LE-PAD (none, unilateral, or bilateral) and CAD. Serum Lp(a) levels were significantly higher in patients with LE-PAD than in those without (31.0 mg/ dL vs. 13.5 mg/dL, p = 0.002). After adjusting for confounding factors, higher Lp(a) levels were independently associated with the prevalence of LE-PAD in all three models (p < 0.001 for all). With respect to LE-PAD severity, serum Lp(a) levels were significantly higher in the bilateral LE-PAD groups than in the group with no LE-PAD (p = 0.005 for all), whereas Lp(a) was not associated with CAD severity. Though Lp(a) levels are associated with the prevalence and severity of LE-PAD, are not associated with the severity of CAD among patients with ACS.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 38 条
[21]   Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study [J].
Magro, Michael ;
Nauta, Sjoerd ;
Simsek, Cihan ;
Onuma, Yoshinobu ;
Garg, Scot ;
van der Heide, Elco ;
van der Giessen, Willem J. ;
Boersma, Eric ;
van Domburg, Ron T. ;
van Geuns, Robert Jan ;
Serruys, Patrick W. .
AMERICAN HEART JOURNAL, 2011, 161 (04) :771-781
[22]  
Matsumoto Y, 1998, J Atheroscler Thromb, V5, P47
[23]   Determinants of peripheral arterial disease in the elderly -: The Rotterdam study [J].
Meijer, WT ;
Grobbee, DE ;
Hunink, MGM ;
Hofman, A ;
Hoes, A .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (19) :2934-2938
[24]   Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes [J].
Mohammedi, Kamel ;
Woodward, Mark ;
Hirakawa, Yoichiro ;
Zoungas, Sophia ;
Williams, Bryan ;
Liu Lisheng ;
Rodgers, Anthony ;
Mancia, Giuseppe ;
Neal, Bruce ;
Harrap, Stephen ;
Marre, Michel ;
Chalmers, John .
DIABETES CARE, 2016, 39 (10) :1796-1803
[25]   Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease [J].
Niccoli, Giampaolo ;
Chin, Diana ;
Scalone, Giancarla ;
Panebianco, Mario ;
Abbolito, Sofia ;
Cosentino, Nicola ;
Jacoangeli, Francesca ;
Refaat, Hesham ;
Gallo, Giovanna ;
Salerno, Gerardo ;
Volpe, Massimo ;
Crea, Filippo ;
De Biase, Luciano .
ATHEROSCLEROSIS, 2016, 246 :214-220
[26]   Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque [J].
Ooi, Esther M. M. ;
Ellis, Katrina L. ;
Barrett, P. Hugh R. ;
Watts, Gerald F. ;
Hung, Joseph ;
Beilby, John P. ;
Thompson, Peter L. ;
Stobie, Paul ;
McQuillan, Brendan M. .
ATHEROSCLEROSIS, 2018, 275 :232-238
[27]   Prevalence of previously unrecognized peripheral arterial disease in patients undergoing coronary angiography [J].
Saleh, Akram ;
Makhamreh, Hanna ;
Qoussoos, Tareq ;
Alawwa, Izzat ;
Alsmady, Moath ;
Salah, Zaid A. ;
Shakhatreh, Ali ;
Alhazaymeh, Lewa ;
Jabber, Mohammed .
MEDICINE, 2018, 97 (29)
[28]   5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions [J].
Serruys, Patrick W. ;
Onuma, Yoshinobu ;
Garg, Scot ;
Vranckx, Pascal ;
De Bruyne, Bernard ;
Morice, Marie-Claude ;
Colombo, Antonio ;
Macaya, Carlos ;
Richardt, Gert ;
Fajadet, Jean ;
Hamm, Christian ;
Schuijer, Monique ;
Rademaker, Tessa ;
Wittebols, Kristel ;
Stoll, Hans Peter .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (11) :1093-1101
[29]  
Sianos Georgios, 2005, EuroIntervention, V1, P219
[30]   Increased lipoprotein(a) is associated with polyvascular disease in patients undergoing coronary artery bypass graft [J].
Song, Pamela ;
Seok, Jin Myoung ;
Kim, Wook Sung ;
Lee, Young Tak ;
Kim, Duk-Kyung ;
Kim, Gyeong-Moon .
ATHEROSCLEROSIS, 2011, 219 (01) :285-290